These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28595663)

  • 1. VISIONS OF STAKEHOLDERS ABOUT INSTUTIONALIZATION OF HEALTH TECHNOLOGY ASSESSMENT IN CHILE: A QUALITATIVE STUDY.
    Lavín CP; Alaniz R; Espinoza M
    Int J Technol Assess Health Care; 2017 Jan; 33(2):303-306. PubMed ID: 28595663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRAMEWORK FOR USER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT THE LOCAL LEVEL: VIEWS OF HEALTH MANAGERS, USER REPRESENTATIVES, AND CLINICIANS.
    Gagnon MP; Desmartis M; Gagnon J; St-Pierre M; Rhainds M; Coulombe M; Tantchou MD; Légaré F
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):68-77. PubMed ID: 25952585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.
    Lee HY; Nguyen TT; Park S; Hoang VM; Kim WH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact assessment of Iran's health technology assessment programme.
    Yazdizadeh B; Mohtasham F; Velayati A
    Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
    Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
    Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAKEHOLDER INVOLVEMENT THROUGHOUT HEALTH TECHNOLOGY ASSESSMENT: AN EXAMPLE FROM PALLIATIVE CARE.
    Brereton L; Wahlster P; Mozygemba K; Lysdahl KB; Burns J; Polus S; Tummers M; Refolo P; Sacchini D; Leppert W; Chilcott J; Ingleton C; Gardiner C; Goyder E
    Int J Technol Assess Health Care; 2017 Jan; 33(5):552-561. PubMed ID: 28868993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment of medicines in Greece: pharmaceutical industry executives' views.
    Armataki E; Karampli E; Kyriopoulos J; Pavi E
    Int J Technol Assess Health Care; 2014 Apr; 30(2):226-32. PubMed ID: 24806287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.
    Wasir R; Irawati S; Makady A; Postma M; Goettsch W; Feenstra T; Buskens E
    PLoS One; 2019; 14(11):e0225626. PubMed ID: 31774854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing the patient's perspective in hospital health technology assessment (HTA): the views of HTA producers, hospital managers and patients.
    Gagnon MP; Desmartis M; Gagnon J; St-Pierre M; Gauvin FP; Rhainds M; Lepage-Savary D; Coulombe M; Dipankui MT; Légaré F
    Health Expect; 2014 Dec; 17(6):888-900. PubMed ID: 23046439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Foundations for the institutionalization of health technology assessment in Chile].
    Castillo-Riquelme M; Santelices C E
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S50-4. PubMed ID: 24861181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between health technology assessment and decision making for the allocation of health resources in Latin America.
    Pichon-Riviere A; Augustovski F; García Martí S; Alfie V; Sampietro-Colom L
    Int J Technol Assess Health Care; 2020 Apr; 36(2):173-178. PubMed ID: 32312340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?
    Verbeek J; Hiligsmann M; Cicchetti A; Marchetti M
    Int J Technol Assess Health Care; 2018 Jan; 34(5):527-534. PubMed ID: 30322414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CONTRIBUTION OF STAKEHOLDER ENGAGEMENT TO THE IMPACT OF A HEALTH TECHNOLOGY ASSESSMENT: AN IRISH CASE STUDY.
    Ryan M; Moran PS; Harrington P; Murphy L; O'Neill M; Whelan M; Teljeur C
    Int J Technol Assess Health Care; 2017 Jan; 33(4):424-429. PubMed ID: 29032786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi.
    Mfutso-Bengo J; Jeremiah F; Kasende-Chinguwo F; Ng'ambi W; Nkungula N; Kazanga-Chiumia I; Juma M; Chawani M; Chinkhumba J; Twea P; Chirwa E; Langwe K; Manthalu G; Ngwira LG; Nkhoma D; Colbourn T; Revill P; Sculpher M
    BMC Health Serv Res; 2023 Apr; 23(1):353. PubMed ID: 37041590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing health technology assessment in Kuwait: a qualitative study of perceived barriers and facilitators.
    Darawsheh B; Germeni E
    Int J Technol Assess Health Care; 2019; 35(6):422-426. PubMed ID: 31771676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When health technology assessment is confidential and experts have no power: the case of Hungary.
    Csanádi M; Löblová O; Ozierański P; Harsányi A; Kaló Z; McKee M; King L
    Health Econ Policy Law; 2019 Apr; 14(2):162-181. PubMed ID: 29576025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.